SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

Discover how a simple saliva test offers a painless and reliable method for early oral cancer detection, potentially ...

A multilevel, navigation-based intervention led to more timely initiation of postoperative radiation therapy vs. usual ...

A new study identifies Florida spot keratopathy (FSK) as a stable, benign eye condition in pets and suggests a possible link ...

A dermatologist has sounded an alarm over the overlooked danger of genital skin cancer, which can strike both women and men, ...

I entered medical school thinking I was going to be a pediatrician. My years as an early care provider and educator had ...

Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results ...

Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...